CSIMarket Company Name, Ticker, Industry, else..
 
Dermata Therapeutics Inc   (NASDAQ: DRMA)
 
Price: $1.2013 $0.00 0.108%
Day's High: $1.2300000190734863 Week Perf: -0.72 %
Day's Low: $ 1.20 30 Day Perf: -12.95 %
Volume (M): 6,949 52 Wk High: $ 6.22
Volume (M$): $ 0 52 Wk Avg: $2.08
Open: $1.23 52 Wk Low: $0.95



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 4
 Employees 9
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Dermata Therapeutics Inc is a biopharmaceutical company that specializes in the development and commercialization of novel prescription dermatological products. The company focuses on providing treatments for various skin conditions and diseases, such as psoriasis, atopic dermatitis, acne, and rosacea. Dermata Therapeutics utilizes innovative technologies and scientific research to create effective and safe therapies for patients.


   Company Address: 3525 Del Mar Heights Rd. San Diego 92130 CA
   Company Phone Number: 800-2543   Stock Exchange / Ticker: NASDAQ DRMA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARQT        0.19% 
EOLS   -12.71%    
MNKD   -4.29%    
PFE   -4.46%    
TEVA   -1.47%    
VTRS   -2.95%    
• View Complete Report
   



Stocks on the Move

The Rollercoaster Ride of Dermata Therapeutics Inc Analyzing Recent Market Trends and Financial Indicators

Published Mon, Aug 19 2024 8:00 PM UTC

The Rollercoaster Ride of Dermata Therapeutics Inc: Analyzing Recent Market Trends and Financial Indicators In the volatile landscape of biotechnology stocks, Dermata Therapeutics Inc (NASDAQ: DRMA) has recently encountered a significant downturn, highlighted by various economic indicators and pivotal company developments. Throughout the month of July and into early August 2...
Stocks on the Move

Navigating Volatility Analyzing Dermata Therapeutics Stock Performance Amidst Market Turbulence and Clinical Ambiguities,

Published Thu, Aug 8 2024 4:31 PM UTC

An In-Depth Analysis of Dermata Therapeutics Inc (DRMA): Stock Performance, Challenges, and Future Outlook Dermata Therapeutics Inc (NASDAQ: DRMA) is a late-stage biotechnology company focused on developing innovative treatments for medical and aesthetic skin conditions. The stock has been under the spotlight due to various news releases and market fluctuations recently, ra...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 1.39
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.02
Working Capital Ratio 3.58
Leverage Ratio (MRQ) 0.53
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -4.88 $
Revenues (TTM) -
Cash Flow (TTM) 0.12 $
Cash 1.1 $
Book Value 0.87 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -929,850
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.